Start with a phone call. Your doctor’s office has a triage line and a nurse will talk it through with you. They are genuinely good at this, they do it all day, and it costs nothing. Most practices have a phone line where a nurse takes calls about whether something needs to be seen, and how soon. It is often not advertised — you ring the main number and ask to speak to the triage nurse. There is no charge and you do not need an appointment to use it.
If it feels more serious than that, go to urgent care. You will usually be seen faster than at a hospital, and the care is good.
If it feels life-threatening, call 911 or go to the emergency room. Do not wait until you are sure.
Which one is yours to decide, not ours. But our advice is to assume it is worse than it looks and take the more cautious road. And trust your body — if it is telling you something is wrong, it is probably right. The best possible outcome of a trip to the emergency room is walking out saying well, that was a waste of an evening — but I feel a lot better knowing it is nothing serious.
Before you call, have these ready. They are what the nurse will ask, and the call goes better when you are not working them out on the phone.
You are not diagnosing yourself by having this ready. You are handing them the things they would otherwise spend the call extracting — and the decision stays entirely theirs.
Writing to the portal instead of calling? The same list works, in that order, in one message. Put the direction it is going and the immune-system line near the top — portal messages get read quickly, and those two change how the rest is read.
One of the things people type into Google most is MGUS but my kidney numbers are getting worse
.
MGUS means a rogue protein and no harm found yet. MGRS means the protein has found the kidney. The difference is a test most people are never offered. This room names it.
Tick the ones that are true right now. Then read the line underneath them — it is there, and not at the bottom of the page, because that is where you need it.
What we would do, as a friend rather than as your doctor. This is our opinion and we stand behind it. It is not medical advice and we are not examining you.
And it is not a one-time reading. If you start feeling worse while you are deciding, move up a level. Nobody has ever been criticised for turning up and being sent home. A false alarm is the best possible outcome here.
The muscle one is on this list for a reason. If you take a statin and your kidney function has slipped, the drug can build up and start breaking muscle down. That releases material the kidneys then have to clear, which damages them further. It is measured with a single cheap blood test called CK. Say the word “rhabdomyolysis” if you have to — it is the thing they will want to rule out.
None of them ticked? Then nothing below this is an emergency, and you can read the rest at your own pace.
The short answer, before anything else.
MGUS means nothing is being harmed. If your kidneys are being harmed, then by definition it is not MGUS — and that changes what happens next.
→ where this is explained: What is happening to you, in your own words
Two specialists, each right about their own part. The blood doctor is watching a protein that is not doing much. The kidney doctor is watching a kidney that is declining. Nobody is asked whether the first is causing the second.
→ where this is explained: What is happening to you, in your own words
Some medicines ask more of a damaged kidney than they ask of a healthy one, which is worth knowing before the next prescription rather than after it.
→ where this is explained: Medicines that ask more of a damaged kidney
The one thing to do next: Worth asking: “I have kidney trouble and an abnormal protein. Has anybody checked whether the protein is what is damaging my kidneys?” and “What is the plan for treating the colony itself, rather than only the kidney damage it causes?” The second one is the question that changes what happens next.
Everything below explains each of those, in whatever order suits you.
People reach this page from completely different places. One was told about a protein years ago and never heard about it again. One has kidney numbers that keep sliding while everyone blames the diabetes. One was handed a biopsy result with the word “idiopathic” on it, which means nobody knows. One was exhausted for months and was told to drink more water.
Pick whichever sounds like you. There is no wrong door and no right order. These are not steps. Each one feeds the next, and the last feeds the first — it is a loop, not a line.
First, what the protein is. Deep in your bone marrow are cells whose job is to make antibodies. Normally thousands of different ones are working at once, each making a slightly different antibody. Sometimes a single cell copies itself into a small colony — a clone — and that colony makes one identical antibody, over and over. That single repeated antibody is what shows up on a blood test as an abnormal protein.
Three names get used for this, and the difference between them is the whole page:
Here is the trap. MGUS is defined by nothing being harmed. So the moment your kidneys are being harmed by that protein, the name MGUS no longer applies — whatever the size of the colony. It has become MGRS. If you are being told “just MGUS” while your kidney numbers are getting worse and you are losing protein into your urine, those two statements cannot both be true.
GRADE A This is a definition, not an opinion. MGUS means no organ damage; organ damage means it is not MGUS.
a small clone → one antibody made over and over → spare pieces reach the kidney → damage that does not depend on the colony being large
“I have kidney trouble and an abnormal protein. Has anybody actually checked whether the protein is what is damaging my kidneys?”
That one question is the whole thing. Most of the time these are being managed as two separate problems by two separate people.
MGRS was only named as a separate condition in 2012. A doctor who trained before then learned a simpler rule: this protein is either cancer or it is harmless. The idea that a colony too small to be cancer can still destroy your kidneys came afterwards, and it is still not universally known outside specialist centres.
Why we are telling you this. Not to make you distrust your doctor. To take the sting out of the conversation. If you have to raise this, you are not telling them they are wrong — you are pointing at something that was defined after most people finished training. That is a far easier sentence for both of you.
GRADE A The 2012 definition is a matter of record.
“I have been reading about MGRS, which I gather was only defined in 2012. Does it fit what is happening to me?”
Diabetes and high blood pressure are the two commonest reasons kidneys fail. When you have one of them, it becomes the explanation, and the search stops. It is usually the right answer — which is exactly why it is dangerous when it is not.
Two things worth knowing, and neither requires you to argue with anybody:
GRADE B Carried from this project’s own work on kidney presentations rather than re-checked against primary literature today. Good enough to raise the question; not good enough to quote as a rule.
“My eye exams have been clean but I am losing a lot of protein. Does that fit with the diabetes being the whole explanation?”
“Idiopathic” means nobody knows the cause. It is an honest word, and it is also where a search stops.
What can be looked for instead. Antibodies are built from two large pieces and two small ones. The small ones are light chains, and they come in two types, called kappa and lambda. A healthy body makes plenty of both. A clone makes only one.
So when the laboratory stains your kidney tissue and finds only kappa, or only lambda, that is not a random finding. It is a fingerprint pointing at a single colony of cells. If both show up together in normal proportions, it points away from MGRS.
GRADE A Staining restricted to one light chain is the established hallmark. This is what the test is for.
“When they stained my biopsy, did they find only one kind of light chain — just kappa, or just lambda?”
If the answer is that it was not looked for, that is not a failure by anybody. It is a question that only gets asked when somebody is already thinking about this diagnosis.
There are two different blood tests here and they do not find the same things.
The older test (you may see it written as SPEP, protein electrophoresis) sorts the proteins in your blood by size and looks for one abnormal spike. It is good, and it is not sensitive enough on its own.
The newer test (the free light chain assay) measures those small spare pieces directly, and compares how much of one type there is against the other. Some clones make only light chains and no whole antibody at all — and those are close to invisible on the older test while showing clearly on the newer one.
GRADE A A normal protein electrophoresis does not rule this out. Light-chain-only disease is a recognised category.
only light chains made → no spike on the old test → “normal” → the search stops → the kidney keeps being damaged
“Has anyone looked for an abnormal protein in my blood? I have read there is a blood test that finds the small ones the older test can miss.”
If they ask which test you mean, it is the serum free light chain assay. You do not need to say that to be taken seriously — but it is here in case you want it.
C3G is another kidney condition, where a part of the immune system called complement switches on and fails to switch off. There is a page about it here.
The connection. In older adults, one of the things that can jam that switch is an abnormal protein — the same kind this page is about. The spare light chains can act against the very protein whose job is to switch complement off. The result looks like C3G on a biopsy, and blocking complement will protect the kidney without doing anything at all about the colony producing the trouble.
GRADE B And a number we are deliberately not printing. This project’s own record holds two figures — one for how often an abnormal protein is present in older C3G patients, and one for how often it is judged to be the cause. They are not the same measurement and we are not going to publish one dressed as the other. What is not in doubt: in adults over fifty, a C3G work-up should include a proper search for a monoclonal protein.
“I have been diagnosed with C3G and I am over fifty. Has anyone looked for an abnormal protein as the cause of it?”
Fatigue is the least specific symptom in medicine. It fits everything, so it settles nothing, and it is very easily explained away.
What makes it worth a second look is not the tiredness on its own. It is tiredness sitting alongside something measurable — protein in the urine, a creatinine that has drifted, swelling that comes and goes, a protein band somebody mentioned once. Any one of those alone gets shrugged off. Together they are a pattern.
You are allowed to say this out loud. “I have been told three different small explanations for three things. Could they be one thing?” is a completely reasonable sentence, and it is the sentence that most often changes the direction of travel.
GRADE U Whether earlier action on non-specific fatigue changes outcomes here has not been tested. U does not mean no. It means the evidence does not settle it either way, which is not the same as evidence that it makes no difference.
“I have been given a separate small explanation for each of these. Could they be one thing?”
Read them in any order and you end up where you started. That is not a weakness in the explanation. It is what the thing is.
So the useful question is not where did this begin. It is which part of it can be reached. The colony can be treated, if anybody looks for it. Drugs that are hard on kidneys can be changed. Acid and blood pressure can be managed. The part that started it is not always the part you can get to.
These are the questions a good history asks. They are not a form and there is no order. Answer the ones that mean something to you and skip the rest. Anything you write here stays on your own machine.
When did you first notice something was not right? Not when you were told — when you noticed. Those are often years apart, and the gap is itself worth saying out loud.
Which way is it going? Better, worse, or level? One number is an event. Two numbers are a direction, and direction is what changes decisions.
What does the swelling do, if there is any? Where it shows up, and whether it is worse in the evening or on waking.
What is your urine actually like? Foam that stays. Colour changes. How often, and whether that has changed.
What changed around the same time? A new medication above all — and say so even if it seems unrelated. Statins matter here specifically.
What have you tried, and what happened? Failed treatments narrow a diagnosis faster than successful ones. What did not work is information, not a wasted trip.
What have you stopped doing? This is the one nobody asks and it often says the most. The stairs, the shopping, the walk you used to take without thinking.
What worries you most about it? Not the medical question — the actual one. It is usually a good question, and it is usually never asked.
This is not a list of things to stop. Stopping a prescribed medicine on your own is its own risk. It is a list of things worth raising, because doses that were right for your kidneys two years ago may not be right for them now.
GRADE A The statin–kidney–muscle interaction is well established and dose-related. This one is on the urgent list at the top of the page for that reason.
You do not need all of these. Take the two that fit and leave the rest.
Number four is the one that changes what happens next. Supportive care protects the kidney from the weather. It does not do anything about the source.
Not a diagnosis. Nothing on this page can give you one, and anybody who claims otherwise from a distance is guessing.
What you have is the shape of a question that is usually never asked, and the words to ask it with. This condition is missed for a specific and unglamorous reason: two careful specialists each look after their own part correctly, and nobody is assigned the middle. You are now standing in the middle, and you can point at it.
Take one sentence from this page. Not seven.
What is on this page and what it rests on. The definitions and the light chain fingerprint are Grade A — established, and you can quote them. The diabetes and eye point is Grade B, carried from our own work and not re-checked against primary literature today. The fatigue question is Grade U, meaning untested rather than untrue.
What we would not print. Two figures in our own record describe the link between C3G and this condition in older adults, and they measure different things. We have said so rather than pick the more striking one. A number that has to be corrected later has already done its damage — a correction never reaches the person who acted on the first version.
Where this came from.
The base for this page was already on disk. It had been there since May 2026, in a document nobody had opened.
Alongside it sat a research review of low-level abnormal proteins, and an analysis of light chains in MGRS and C3G.
This page was not written this afternoon. It was found, and rewritten.